Introduction
Yellow fever (YF) virus is the prototype of the family Flaviviridae (Westaway et al., 1985) and is responsible for the disease YF. Wild-type YF virus is still found in Africa and South America and the first Aedes aegyptiborne, urban epidemic in 40 years occurred in 1986 (DeCock et al., 1988) . Live attenuated vaccines have been developed to prevent YF and are known as 17D (Theiler & Smith, 1937) and the French neurotropic vaccine (FNV) (Mathis et al., t928) . The 17D vaccine consists of two distinct substrains (17D-204 and 17DD), which have been maintained as independent passage series from the original 17D virus and are both used as vaccines today. Four groups have prepared monoclonal antibodies (MAbs) against the 17D-204 vaccine Geske et al., 1983; Gould et al., 1985; Barrett et al. 1989 ) and all but the latter of these groups have described MAbs that are 17D-204 strainspecific. Gould and co-workers have also described MAbs prepared against the FNV virus and Asibi virus (the wild-type parent to 17D vaccines) Cammack & Gould, 1986) .
One of the two MAbs prepared against FNV virus was shown to be vaccine-specific (i.e. recognized 17D-204, 17DD and FNV only) and more recently Gould et al. (1989) have reported an envelope protein-reactive MAb prepared against Asibi virus that is wild-type specific.
In this paper we describe the identification of MAbs that will distinguish wild-type YF viruses from 17D-204 vaccine viruses, but only when the virus is grown in cells of mosquito origin. Two of the MAbs were able to separate all vaccine strains from wild-type strains in neutralization tests. The specificity and significance of these MAbs and their reactivities are discussed. al., 1983 and unpublished observations) , except for 4G2, which was prepared against dengue 2 virus (DEN-2) (Gentry et al., 1982) and 1B7, prepared against dengue 3 virus (DEN-3) (Henchal et al., 1985) .
Methods
Indirect immunofluorescence tests. Twenty-five cm 3 flasks of SW13, Veto or C6/36 cells were infected at an m.o.i, of 0.5 with each of the viruses used in the studies. After 2 days of incubation at 37 °C (or 4 days at 28 °C for C6/36 cells) cells were trypsinized, placed on multispot slides, air-dried and fixed using cold acetone. Indirect immunofluorescence was performed by addition of MAbs, diluted in phosphatebuffered saline (PBS) at 1:100 on SWl 3 or Vero cells, and 1:50 on C6/36 cells or adult A. aegypti mosquito brain tissues. After 30 min at 37 °C, the MAb was removed and the multispot slides were washed in PBS. Goat anti-mouse IgG-fluorescein isothiocyanate (FITC) was added to the multispot slides and incubated for 30 min at 37 °C. The multispot slides were washed with PBS and then water, dried and mounted to examine fluorescence under u.v. light.
Mosquitoes and mosquito infection. A. aegypti mosquitoes (Rexville strain) were kindly provided by Dr D. J. Gubler (Dengue Branch, DVBVD, CDC, San Juan, Puerto Rico) and had undergone three generations of colonization at the CDC, Fort Collins.
Mosquitoes were inoculated parenterally or became exposed to YF virus by feeding on cotton pledgets soaked with a warm infectious meal (37.8 °C) consisting of equal volumes of human red blood cells (washed once in Alsever's solution and three times in PBS pH 7-5) and virus. The virus was in the form of freshly harvested, infected suckling mouse brains. One brain was triturated in 1 ml MEM containing 2% foetal calf serum and centrifuged at 5000 r.p.m, for 15 min.
Mosquitoes were exposed to the virus for 15 min and fully engorged mosquitoes were then sorted and placed in cages made from 1 gallon ice-cream containers and incubated at 26.7 °C and 80% relative humidity.
Mosquito infection with YF virus was determined by examining midgut and head tissues (after 14 days extrinsic incubation) for specific YF antigen by immunofluorescence. The FITC conjugate was a CDC reagent (polyclonal anti-Asibi, M15154, lot 2, 19/1/81) and had a titre of 1:40. Mosquito 'head squashes' were made on standard microscope slides and fixed for 10min in cold (-20°C) acetone. Conjugated antibody was incubated with mosquito head squashes for 30 rain at 37 °C in a humidified chamber, rinsed once in PBS for 15 min, once in 'buffered water' (PBS without NaC1) for 15 min and air-dried. Evans blue was added to the conjugate as a counterstain. Slides were mounted in polyvinyl alcohol and examined with an Olympus BHS incident light fluorescence microscope and a xenon light source and with 490 nm and 530 nm barrier filters.
Plaque reduction neutralization tests. These were performed using constant antibody (1:20) and varying virus dilutions to produce a serum neutralization index for each antibody, as described by , except that the overlay contained 1% Noble agar and 0.015% DEAE-dextran. Plaques were stained using neutral red and counted at 7 days post-infection.
Results

YF epitope specificity of flavivirus cross-reacting MAbs
We wished to identify epitopes of the YF envelope protein that were specific to wild-type viruses. Experiments with MAbs prepared against YF virus failed to identify epitopes specific to wild-type viruses (data not shown). As an alternative approach, envelope proteinreactive MAbs, prepared against other flaviviruses, and which were broadly reactive, were analysed (Table 1) 
Density of epitopes expressed in C6/36 and SW13 cells
It was observed that fluorescence was weak when individual MAbs were used to detect expression of epitopes in C6/36 cells, but strong fluorescence was seen 
Group (E-4b) + + * Designations refer to epitopes described by Roehrig et al. (1983) , Gentry et al. (1982) and Henchal et al. (1985) . using the same MAbs, at the same concentration, in SW13 ceils. Titration of the MAbs showed that fluorescence was lost when the MAbs were diluted greater than 1 : 100 on mosquito cells, although the same MAbs still gave fluorescence when titrated to dilutions greater than 1:1000 on SW13 cells. The weak fluorescence was shown not to be an artefact, by mixing two or more affinity-purified MAbs so that the overall dilution of each MAb in the mixture was 1:50. This resulted in strong fluorescence when compared to the weak fluorescence observed when each individual MAb was used at a dilution of I : 50. Hence, the epitope density for any particular MAb was less on C6/36 than on SW 13 cells and a cumulative epitope staining effect was observed with mixed MAb preparations.
Reaction of MAbs with different wild-type YF viruses
To determine whether or not the five MAbs (1B7, 4G2, 6B3B-3, 6BID-2 and 6A3C-4) described above would distinguish African from South American wild-type viruses, isolates from different countries in the two continents were analysed. All eight African lArD25865, 
Reaction of MAbs with different YF vaccine viruses
Examples of the three different YF vaccine viruses (17D-204, 17DD and FNV) produced by different manufacturers were analysed with the six MAbs ( 
Serum neutralization indices of MAbs against YF viruses
As we had observed antigenic differences between YF viruses grown in vertebrate and invertebrate cells it was of interest to determine whether there were also biological differences. This possibility was investigated by growing various YF viruses in SW13 and C6/36 cells and testing them in plaque reduction neutralization tests (to give serum neutralization indices) with the five MAbs ( t Plaque reduction neutralization tests were performed as described in Methods and the antibody titres are expressed as log,0 reduction of virus titre. A figure of zero indicates the virus was not neutralized by the MAb.
Infectivity of the viruses for mosquitoes
Adult A. aegyptimosquitoes were orally exposed to either 17D-204-India, 17DD-Colombia or Asibi virus and examined for infection (Table 5 ). All three viruses infected similar proportions of mosquitoes, as determined by the presence of viral antigen in mosquito midgut tissue by indirect immunofluorescence. However, only Asibi virus was observed to disseminate to head tissues, as demonstrated by the presence of viral antigen in head squash preparations. Therefore neither 17D-204 nor 17DD vaccine viruses have the ability to disseminate.
Discussion
In this paper we have described five MAbs that will distinguish wild-type YF viruses from 17D-204 vaccine viruses when the viruses are grown in mosquito, but not vertebrate, cell cultures. However, 17DD and FNV viruses could not be distinguished from wild-type YF viruses, nor African from South American wild-type viruses. A pattern of MAb reactivities was observed in vivo in adult A. aegypti mosquitoes that differed from that seen in the A. albopictus cell culture derived from mosquito larvae.
The reason for the differences between 17D-204, and 17DD and FNV vaccine viruses is unclear. Loss of the five epitopes described in this paper when the virus is grown in mosquito cells appears to correlate with attenuation of Asibi virus to 17D-204 vaccine. However, Barrett, 1987) . Similarly, 17D-204 virus is antigenically different depending on whether the virus is grown in vertebrate or mosquito cells. We cannot say whether or not the same is true for 17DD virus, as it is conceivable that other MAbs may recognize epitopes that will distinguish between virus grown in different cell types. Also the process of attenuation of {he French viscerotropic virus to produce the FNV virus does not involve the loss of the epitopes described in this paper. Thus it would appear that the mosquito non-competence of 17D-204, 17DD (Table 5 ) and FNV (Deubel et al., 1981) Boere et al. (1986) who have reported MAbs that distinguish virulent from avirulent strains of Semliki Forest virus in neutralization tests. Grady & Kinch (1985) have reported studies with La Crosse virus which show one MAb that neutralizes virus grown in BHK-21 cells, but not virus grown in A. albopictus cells; another MAb showed the reverse neutralization pattern. Interestingly, the latter MAb recognized an epitope that is common to the California serogroup. Thus, the MAb reactivity differences of MAbs with a virus groupcommon specificity reported by Grady & Kinch (1985) and ourselves in this paper may represent a common phenomenon for arthropod-borne viruses. Also, James & Millican (1986) have shown host-adaptive neutralization of bunyaviruses, but did not cite the bunyavirus specificity of the MAb used in their studies.
It is not known why only the flavivirus group-common reacting MAbs that were prepared against viruses other than YF can detect antigenic differences between YF virus strains. Also, it is unclear why some, but not all (i.e. five out of eight MAbs examined) flavivirus crossreactive MAbs detect differences, especially since three MAbs prepared against SLE virus that recognize the same antigenic site (E-4b, see Table 1) give different reactions with YF viruses. It was interesting to note that comparison of the expression of viral epitopes in different cell substrates permitted further delineation, or fine tuning, of the SLE virus epitopes previously described (Roehrig et al., 1983 ) (see Table 1 ). The two MAbs defining the E-3 epitope and the three MAbs that are E-4b flavivirus group-reactive had different reactivity patterns on C6/36 and A. aegypti cells within the original epitope designation. Possibly the spatial and/or conformational positions of flavivirus cross-reactive epitopes are different for YF and SLE viruses. Cammack & Gould (1986) have reported different spatial locations of an epitope for different strains of YF virus (17D-204-U.K. and Asibi virus) and Monath et al. (1986) have demonstrated antigenic differences between different strains of dengue 2 viruses with MAbs in antigenic signature analyses. Also, we have observed differences in the quality of fluorescence between C6/36 and SW13 cells, which may be related to differences in presentation of epitopes in the two cell systems. Finally, the MAbs described in this paper recognize epitopes on the envelope protein. This protein is glycosylated for many flaviviruses, so it is possible that the differences in reactivities of the MAbs described in this paper relates to the absence of sialic acid and/or different phospholipid content in invertebrate cells compared to vertebrate cells (Stollar, 1976) . Similarly, this may explain the differences between C6/36 cell culture from mosquito larvae when compared to A. aegypti mosquitoes. Whatever the mechanism for the differences between the cell types, the result is that some envelope protein epitopes are not expressed on virus grown in mosquito cells. Thus, virus grown in mosquito cells is antigenically and biologically different to that grown in vertebrate cells. This result may have consequences for the antigenicity of inactivated or live attenuated vaccines prepared in either vertebrate or invertebrate cells. Similarly, the propagation of virus in mosquitoes may result in the selection of antigenically distinct virus when compared to that grown in cell culture. Clearly an antigenic comparison of viruses passaged in mosquitoes and cell culture with MAbs will be necessary to investigate this possibility.
